|
|
Previous Article | Table of Contents | Next Article 
Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's
lymphoma
F Lo Coco, BH Ye, F Lista, P Corradini, K Offit, DM Knowles, RS Chaganti and R Dalla-Favera
Department of Pathology, College of Physicians & Surgeons, Columbia
University, New York, NY 10032.
The pathogenesis of non-Hodgkin's lymphoma (NHL) with a large cell
component (DLLC, including diffuse large cell, DLCL; diffuse mixed cell,
MX-D; and immunoblastic, IMB) is unknown. A novel candidate proto-
oncogene, BCL6, that is involved in chromosome band 3q27 aberrations in NHL
has been recently identified. We have investigated the incidence and
disease-specificity of BCL6 rearrangements in a large panel of lymphoid
tumors, including acute and chronic lymphoid leukemias (96 cases), various
NHL types (125 cases), and multiple myelomas (23 cases). BCL6
rearrangements were found in 16/45 (35.5%) DLLC, more frequently in DLCL
(15/33, 45%) than in MX-D (1/10, 10%), in 2/31 (6.4%) follicular NHL, and
in no other tumor types. BCL6 rearrangements represent the first genetic
lesion specifically and recurrently associated with DLLC and should prove
useful for understanding the pathogenesis as well as for the clinical
monitoring of these tumors.
Volume 83,
Issue 7,
pp. 1757-1759,
04/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. M. Cady, B. P. O'Neill, M. E. Law, P. A. Decker, D. M. Kurtz, C. Giannini, A. B. Porter, P. J. Kurtin, P. B. Johnston, A. Dogan, et al.
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
J. Clin. Oncol.,
October 10, 2008;
26(29):
4814 - 4819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Prakash and S. H Swerdlow
Nodal aggressive B-cell lymphomas: a diagnostic approach
J. Clin. Pathol.,
October 1, 2007;
60(10):
1076 - 1085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Chen, X.-T. Hu, A. C. Liang, W.-Y. Au, C.-C. So, M. L. Wong, L. Shen, Q. Tao, K.-M. Chu, Y.-L. Kwong, et al.
High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma
Blood,
October 1, 2006;
108(7):
2373 - 2383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Wallace, D. Shen, G. F. Reed, M. Miyanaga, M. Mochizuki, H. N. Sen, S. S. Dahr, R. R. Buggage, R. B. Nussenblatt, and C.-C. Chan
Detection of the bcl-2 t(14;18) Translocation and Proto-Oncogene Expression in Primary Intraocular Lymphoma.
Invest. Ophthalmol. Vis. Sci.,
July 1, 2006;
47(7):
2750 - 2756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos
Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma
J. Clin. Oncol.,
September 10, 2005;
23(26):
6351 - 6357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A. O'Connor
Targeting Histones and Proteasomes: New Strategies for the Treatment of Lymphoma
J. Clin. Oncol.,
September 10, 2005;
23(26):
6429 - 6436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Harris, J. Mostecki, and P. B. Rothman
Repression of an Interleukin-4-responsive Promoter Requires Cooperative BCL-6 Function
J. Biol. Chem.,
April 1, 2005;
280(13):
13114 - 13121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Piazza, J. A. Costoya, T. Merghoub, R. M. Hobbs, and P. P. Pandolfi
Disruption of PLZP in Mice Leads to Increased T-Lymphocyte Proliferation, Cytokine Production, and Altered Hematopoietic Stem Cell Homeostasis
Mol. Cell. Biol.,
December 1, 2004;
24(23):
10456 - 10469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rivailler, A. Carville, A. Kaur, P. Rao, C. Quink, J. L. Kutok, S. Westmoreland, S. Klumpp, M. Simon, J. C. Aster, et al.
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host
Blood,
September 1, 2004;
104(5):
1482 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Katzenberger, G. Ott, T. Klein, J. Kalla, H. K. Muller-Hermelink, and M. M. Ott
Cytogenetic Alterations Affecting BCL6 Are Predominantly Found in Follicular Lymphomas Grade 3B with a Diffuse Large B-Cell Component
Am. J. Pathol.,
August 1, 2004;
165(2):
481 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Smith and M. Sigvardsson
The roles of transcription factors in B lymphocyte commitment, development, and transformation
J. Leukoc. Biol.,
June 1, 2004;
75(6):
973 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Akasaka, I. S. Lossos, and R. Levy
BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma
Blood,
August 15, 2003;
102(4):
1443 - 1448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Niu, G. Cattoretti, and R. Dalla-Favera
BCL6 Controls the Expression of the B7-1/CD80 Costimulatory Receptor in Germinal Center B Cells
J. Exp. Med.,
July 21, 2003;
198(2):
211 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pasqualucci, A. Migliazza, K. Basso, J. Houldsworth, R. S. K. Chaganti, and R. Dalla-Favera
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
Blood,
April 15, 2003;
101(8):
2914 - 2923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood,
February 15, 2003;
101(4):
1220 - 1235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Wlodarska, P. Nooyen, B. Maes, J. I. Martin-Subero, R. Siebert, P. Pauwels, C. De Wolf-Peeters, and A. Hagemeijer
Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma
Blood,
January 15, 2003;
101(2):
706 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Butler, S. Iida, D. Capello, D. Rossi, P. H. Rao, P. Nallasivam, D. C. Louie, S. Chaganti, T. Au, R. D. Gascoyne, et al.
Alternative Translocation Breakpoint Cluster Region 5' to BCL-6 in B-cell Non-Hodgkin's Lymphoma
Cancer Res.,
July 15, 2002;
62(14):
4089 - 4094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Biagi and J. F. Seymour
Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation
Blood,
May 29, 2002;
99(12):
4265 - 4275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Melnick, G. Carlile, K. F. Ahmad, C.-L. Kiang, C. Corcoran, V. Bardwell, G. G. Prive, and J. D. Licht
Critical Residues within the BTB Domain of PLZF and Bcl-6 Modulate Interaction with Corepressors
Mol. Cell. Biol.,
March 15, 2002;
22(6):
1804 - 1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood,
January 15, 2002;
99(2):
409 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Steele-Perkins, W. Fang, X.-H. Yang, M. Van Gele, T. Carling, J. Gu, I. M. Buyse, J. A. Fletcher, J. Liu, R. Bronson, et al.
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily
Genes & Dev.,
September 1, 2001;
15(17):
2250 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos, C. D. Jones, R. Warnke, Y. Natkunam, H. Kaizer, J. L. Zehnder, R. Tibshirani, and R. Levy
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
Blood,
August 15, 2001;
98(4):
945 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Seitz, M. Hummel, I. Anagnostopoulos, and H. Stein
Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type
Blood,
April 15, 2001;
97(8):
2401 - 2405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Migliazza, F. Bosch, H. Komatsu, E. Cayanis, S. Martinotti, E. Toniato, E. Guccione, X. Qu, M. Chien, V. V. V. Murty, et al.
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia
Blood,
April 1, 2001;
97(7):
2098 - 2104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hyjek, A. Chadburn, Y. F. Liu, E. Cesarman, and D. M. Knowles
BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus
Blood,
January 1, 2001;
97(1):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Arber
Molecular Diagnostic Approach to Non-Hodgkin's Lymphoma
J. Mol. Diagn.,
November 1, 2000;
2(4):
178 - 190.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. D. Huynh, W. Fischle, E. Verdin, and V. J. Bardwell
BCoR, a novel corepressor involved in BCL-6 repression
Genes & Dev.,
July 15, 2000;
14(14):
1810 - 1823.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. S. Lossos and R. Levy
Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene
Blood,
July 15, 2000;
96(2):
635 - 639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hosokawa, Y. Maeda, R. Ichinohasama, I. Miura, M. Taniwaki, and M. Seto
The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma
Blood,
April 15, 2000;
95(8):
2719 - 2721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Starostik, A. Greiner, A. Schultz, A. Zettl, K. Peters, A. Rosenwald, M. Kolve, and H. K. Muller-Hermelink
Genetic aberrations common in gastric high-grade large B-cell lymphoma
Blood,
February 15, 2000;
95(4):
1180 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Lossos and R. Levy
Mutation analysis of the 5' noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity
Blood,
February 15, 2000;
95(4):
1400 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Capello, U. Vitolo, L. Pasqualucci, S. Quattrone, G. Migliaretti, L. Fassone, C. Ariatti, D. Vivenza, A. Gloghini, C. Pastore, et al.
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia
Blood,
January 15, 2000;
95(2):
651 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Harris, C.-C. Chang, M. T. Berton, N. N. Danial, J. Zhang, D. Kuehner, B. H. Ye, M. Kvatyuk, P. P. Pandolfi, G. Cattoretti, et al.
Transcriptional Repression of Stat6-Dependent Interleukin-4-Induced Genes by BCL-6: Specific Regulation of Ivarepsilon Transcription and Immunoglobulin E Switching
Mol. Cell. Biol.,
October 1, 1999;
19(10):
7264 - 7275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yoshida, T. Fukuda, M. Hatano, H. Koseki, S.-i. Okabe, K. Ishibashi, S. Kojima, M. Arima, I. Komuro, G. Ishii, et al.
The role of Bcl6 in mature cardiac myocytes
Cardiovasc Res,
June 1, 1999;
42(3):
670 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. ALIZADEH, M. EISEN, R.E. DAVIS, C. MA, H. SABET, T. TRAN, J. I. POWELL, L. YANG, G.E. MARTI, D. T. MOORE, et al.
The Lymphochip: A Specialized cDNA Microarray for the Genomic-scale Analysis of Gene Expression in Normal and Malignant Lymphocytes
Cold Spring Harb Symp Quant Biol,
January 1, 1999;
64(0):
71 - 78.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M.H.H. Kramer, J. Hermans, E. Wijburg, K. Philippo, E. Geelen, J.H.J.M. van Krieken, D. de Jong, E. Maartense, E. Schuuring, and P.M. Kluin
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
Blood,
November 1, 1998;
92(9):
3152 - 3162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cesarman, A. Chadburn, Y.-F. Liu, A. Migliazza, R. Dalla-Favera, and D. M. Knowles
BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical Outcome
Blood,
October 1, 1998;
92(7):
2294 - 2302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Larocca, D. Capello, A. Rinelli, S. Nori, A. Antinori, A. Gloghini, A. Cingolani, A. Migliazza, G. Saglio, S. Cammilleri-Broet, et al.
The Molecular and Phenotypic Profile of Primary Central Nervous System Lymphoma Identifies Distinct Categories of the Disease and Is Consistent With Histogenetic Derivation From Germinal Center-Related B Cells
Blood,
August 1, 1998;
92(3):
1011 - 1019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Niu, B. H. Ye, and R. Dalla-Favera
Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor
Genes & Dev.,
July 1, 1998;
12(13):
1953 - 1961.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Nicolaides, S. Dimou, and N. Pavlidis
Prognostic Factors in Aggressive Non-Hodgkin's Lymphomas
Oncologist,
June 1, 1998;
3(3):
189 - 197.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Gaidano, A. Carbone, and R. Dalla-Favera
Genetic Basis of Acquired Immunodeficiency Syndrome-Related Lymphomagenesis
J Natl Cancer Inst Monographs,
April 1, 1998;
1998(23):
95 - 100.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Dhordain, O. Albagli, R. J. Lin, S. Ansieau, S. Quief, A. Leutz, J.-P. Kerckaert, R. M. Evans, and D. Leprince
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
PNAS,
September 30, 1997;
94(20):
10762 - 10767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fukuda, T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, et al.
Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation
J. Exp. Med.,
August 4, 1997;
186(3):
439 - 448.
[Abstract]
| |